By Elric Langton | 27th September 2021
Please do not confuse this latest overview on SkinBioTherapeutics Plc (SBTX) to promote to boost the share price, and I do not need to do this because it has established a solid foundation around 58-60p. Instead, I hope to clarify what I feel some investors may have overlooked key milestones, as well as significant β¦